INTRODUCTION
============

Cells are exquisitely sensitive to their environments. Cells not only respond to their environments but also influence them; for example, through creation and maintenance of extracellular matrix (ECM). Cells maintain the homeostasis of ECM by regulating the production of secreted collagens, other ECM components, and ECM-modifying enzymes. Loss of this regulation can result in cell death or fibrosis. One group of ECM regulators is the transforming growth factor beta (TGF-β) family. TGF-β signaling regulates collagen synthesis and in turn is regulated by collagens and responsive to changes in matrix stiffness ([@B4]; [@B16]). However, in vitro studies are limited in their ability to recapitulate the complexities of cell--matrix interactions, much less the indirect interactions of cells within organs and ECM, and in vivo systems have thus far been scarce.

We have established *Caenorhabditis elegans* as an in vivo model to study the interplay between TGF-β signaling and ECM. The *C. elegans* ECM includes both basement membrane, which lines internal organs, and cuticle, which is secreted apically from hypodermal (epidermal) tissue to protect the organism and is shed at each molt ([@B17]; [@B28]; [@B12]). The cuticle is composed of multiple collagen layers coated by a lipid-rich epicuticle ([@B5]; [@B6]). Cuticle collagens are encoded by a large multigene family with more than 170 members. Some cuticle collagens are expressed in each developmental stage in which a cuticle is synthesized, while others are expressed stage specifically ([@B14]). Accordingly, the cuticle at each developmental stage contains different specific collagens and is organized into distinct structures. For example, the lateral ridges known as alae are only present on L1, dauer, and adult cuticles ([@B28]).

The TGF-β family includes bone morphogenetic proteins (BMPs), highly conserved members that include vertebrate BMPs, *Drosophila* Dpp, and *C. elegans* DBL-1. The DBL-1/BMP ligand is not only highly conserved at the sequence level but also signals through a conserved, canonical pathway. This pathway includes the type I and type II receptors and intracellular Smad signal transducers, which are activated by the receptor complex and regulate the transcription of target genes ([@B13]). The DBL-1 ligand is secreted by ventral cord motor neurons that are nestled in the basal side of the hypodermis ([@B35]). Interestingly, a body size-regulating TGF- β ligand is also produced by motor neurons in *Drosophila* ([@B25]). Receptors and Smad signal transducers for *C. elegans* DBL-1 are present in the hypodermis, which receives the DBL-1 signal ([@B39]; [@B38]). The DBL-1 signaling pathway transcriptionally regulates gene products that function in a number of developmental and homeostatic functions, but the pathway is not essential for viability. There is growing evidence that DBL-1 signaling modulates cuticle structure and function. For example, the DBL-1 pathway plays a major role in regulating body size and morphology, permeability to drugs, and resistance to infection, traits associated with cuticle function ([@B31]). Loss of *dbl-1* causes physical changes in cuticle morphology ([@B31]). Finally, genes encoding cuticle collagens and other ECM constituents and enzymes are known transcriptional targets of the DBL-1 pathway ([@B21]; [@B22]; [@B29]).

We previously characterized four DBL-1--regulated collagen genes, *col-41*, *rol-6*, *col-141*, and *col-142*, and demonstrated that they are involved in body size regulation ([@B23]). Here we report that these four DBL-1--regulated collagens reciprocally modulate the DBL-1 pathway. Using three different activity reporters, we show that depletion of individual collagen genes impacts the DBL-1 pathway at the levels of Smad activity, DBL-1 protein, and *dbl-1* expression. We propose a model in which the presence of these cuticle collagens modifies properties of the cuticle to which DBL-1--expressing cells are sensitive.

RESULTS
=======

Depletion of DBL-1--regulated cuticle collagen gene products impacts DBL-1 pathway activity
-------------------------------------------------------------------------------------------

To determine whether cuticle collagens affect DBL-1 pathway activity, we used an artificial transcriptional reporter containing multiple Smad-binding sites driving expression of GFP (RAD-SMAD reporter; [@B36]). We used RNA interference (RNAi) to deplete expression of four cuticle collagen genes, *col-41*, *rol-6*, *col-141,* and *col-142*, in animals carrying this RAD-SMAD reporter. RNAi was performed with dsRNA targeting the gene-specific amino-termini that do not encode Gly-X-Y repeats. At the L4 stage, depletion of *rol-6* caused significant reduction in RAD-SMAD activity in the hypodermis (\>40% reduction, *p* \< 0.001; [Figure 1A](#F1){ref-type="fig"}). Compared with control animals fed bacteria carrying the empty vector, the depletion of *col-141* or *col-142* reduced RAD-SMAD activity in L4 animals (20--25% reduction). The reduction in activity was statistically significant in some but not all trials. In 1-d-old young adults, a more pronounced reduction in fluorescence was seen after *rol-6, col-141,* and *col-142* depletion (50--80% reduction, *p* \< 0.001; [Figure 1B](#F1){ref-type="fig"}). At both L4 and adult stages, RNAi targeting *col-41* led to a large variance in fluorescence intensity between individual nuclei, with many nuclei showing reduced expression ([Figure 1, A and B](#F1){ref-type="fig"}). We conclude that DBL-1 Smad signaling in the hypodermis is somehow impacted by the collagen composition of the cuticle.

![Loss of cuticle collagen gene function reduces activity of the DBL-1/BMP pathway. (A) L4 animals. (B) Young adults. RNAi was used to deplete collagen gene function. Pathway activity was assayed using a reporter containing Smad-binding sites. AU: arbitrary units. Each data point depicts the fluorescence intensity of an individual nucleus. Bars show mean and SD of the data. Statistical significance compared with control was determined by Brown--Forsythe and Welch analysis of variance (ANOVA) tests. \*\**p* \< 0.01; \*\*\**p* \< 0.001.](mbc-31-825-g001){#F1}

Intensity of GFP::DBL-1 is reduced on loss of DBL-1--regulated collagens
------------------------------------------------------------------------

The effect of collagen gene manipulation on the RAD-SMAD transcriptional reporter could occur either at the level of the ligand or on downstream components of the signaling pathway, or possibly both. To distinguish between these possibilities, we first asked whether collagen gene manipulation alters DBL-1 protein distribution. We quantified fluorescence of functional GFP-tagged DBL-1 expressed from an integrated transgene (*dbl-1(oe)*) in animals fed on bacteria transformed with different RNAi targets ([@B31]). We found that RNAi depletion of any of the collagen products of genes *col-41, rol-6, col-141,* or *col-142* reduces the intensity of GFP::DBL-1 fluorescence in adults compared with our control (C06C3.5 pseudogene RNAi) (35--85% reduction depending on the gene; [Figure 2B](#F2){ref-type="fig"}), although the reduction on *col-41(RNAi)* does not reach statistical significance (*p* = 0.26). These results support the RAD-SMAD experiment results ([Figure 1](#F1){ref-type="fig"}). We also found that RNAi of *col-41*, but not of *rol-6*, caused a significant reduction in GFP intensity at the L4 stage (∼40% reduction for *col-41(RNAi)*; [Figure 2A](#F2){ref-type="fig"}). As in the RAD-SMAD experiment, RNAi of *col-41* caused a large variance in fluorescence intensity ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). Finally, we verified these RNAi results in a mutant background: *rol-6(e187n1270)*, a loss-of-function mutant (hereafter *rol-6(lf)*; [@B18]). We measured the fluorescence intensity of GFP::DBL-1 in the *rol-6(lf);dbl-1(oe)* strain compared with *dbl-1(oe)*. In *rol-6(lf)* mutants, GFP::DBL-1 fluorescence was significantly reduced by ∼25% in L4 animals ([Figure 2A](#F2){ref-type="fig"}) and slightly, but not significantly, reduced in adults ([Figure 2B](#F2){ref-type="fig"}). Taken together, these results are consistent with the conclusion that loss of these cuticle collagen isoforms leads to reduction in DBL-1 protein levels ([Figure 2](#F2){ref-type="fig"}). The reduced pathway signaling, as evidenced by reduced RAD-SMAD activity ([Figure 1](#F1){ref-type="fig"}), is therefore likely due, at least in part, to changes in DBL-1 accumulation. In addition to these four DBL-1--regulated collagens, loss of a subset of other cuticle collagens, but not all tested, also reduces GFP::DBL-1 accumulation ([@B19]).

![GFP::DBL-1 accumulation responds to manipulation of cuticle collagen genes. (A) L4 animals. (B) Young adults. A strain carrying *texIs100*, which expresses functional GFP-tagged DBL-1, was treated with collagen RNAi or crossed with *rol-6(lf)* as indicated. Fluorescence intensity was measured in L4 (A) or 1-d-old adults (B). AU: arbitrary units. Each data point depicts the intensity in a single animal. Bars show mean and SD of the data. Statistical significance compared with control was determined by Brown--Forsythe and Welch ANOVA tests. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.](mbc-31-825-g002){#F2}

Manipulation of DBL-1--regulated cuticle collagen genes suppresses long body size phenotype of *dbl-1* overexpression
---------------------------------------------------------------------------------------------------------------------

We previously showed that cuticle collagen genes are effectors of DBL-1 body size regulation ([@B23]). In the previous study, using targeted RNAi, overexpression strains, and loss-of-function mutants, we found that *col-41* is a positive regulator, *rol-6* is a dose-dependent regulator, and *col-141* is a negative regulator of body size ([@B23]). To elucidate further how these cuticle collagens interact with the DBL-1 pathway in body length regulation, we capitalized on the strain described above in which overexpression of functional GFP-tagged DBL-1 results in a long body size. First, we examined the interaction of TLG281 (*dbl-1(oe)*) with RNAi targeting *col-41* or *rol-6,* which cause small body size phenotypes in the wild type. If these genes act downstream of *dbl-1* for body size regulation, we expect their depletion to suppress the long body size phenotype of *dbl-1(oe)*. *dbl-1(oe)* animals fed on bacteria expressing *col-41(RNAi)* showed a significant reduction of their long body size in adult animals compared with our control (pseudogene C06C3.5 RNAi) ([Figure 3B](#F3){ref-type="fig"}). We also observed that feeding *rol-6(RNAi)* caused a significant reduction in the long body size phenotype of *dbl-1(oe)* in L4 and adult animals ([Figure 3, A and B](#F3){ref-type="fig"}). Finally, we examined *rol-6(lf)* mutants that result in reduced body length in wild-type animals ([@B18]; [@B23]). In CS636 (*rol-6(lf)* expressing GFP::DBL-1), we observed a significant reduction of the long body size phenotype compared with *dbl-1(oe)* animals for both L4 and adult stages ([Figure 3, A and B](#F3){ref-type="fig"}). Together, these results support our hypothesis that *col-41* and *rol-6* act downstream of DBL-1 to regulate body size.

![Genetic interactions between cuticle collagen genes and DBL-1 overexpression in body size regulation. (A) L4 animals. (B) Young adults. A strain carrying *texIs100*, a multicopy array that overexpresses GFP::DBL-1 causing a long body size phenotype, was treated with collagen RNAi or crossed with *rol-6(lf)* as indicated. Body length was measured in L4 (A) or 1-d-old adults (B). AU: arbitrary units. Each data point depicts the length of an individual animal. Bars show mean and SD of the data. Statistical significance compared with control was determined by Brown--Forsythe and Welch ANOVA tests. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.](mbc-31-825-g003){#F3}

In a previous study, we showed that *col-141(RNAi)* causes an increase in body size, while overexpression of *col-141* and *col-142* reduces body size in wild-type animals ([@B23]), suggesting that COL-141 and COL-142 negatively impact body length in *C. elegans*. We tested for genetic interactions between *dbl-1(oe)* and *col-141(RNAi)* or *col-142(RNAi).* If these genes act independently in body size regulation, then we would expect additive effects, with RNAi of *col-141* or *col-142* further increasing the long body size of *dbl-1(oe).* When *col-141* or *col-142* were depleted by RNAi in the *dbl-1(oe)* background, no further increase in body size was seen ([Figure 3B](#F3){ref-type="fig"}). This result is consistent with these genes acting in the same pathway as DBL-1 to regulate body size. Combined with our previously published data ([@B23]) and the results from the reporter constructs ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}), these new results ([Figure 3](#F3){ref-type="fig"}) provide evidence of bidirectional signaling between the DBL-1 pathway and cuticle collagen genes.

DBL-1--regulated collagens affect expression of a *dbl-1* transcriptional reporter
----------------------------------------------------------------------------------

We observed that the genetic manipulation of cuticle collagens caused a reduction in GFP::DBL-1 protein levels ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}), but these experiments do not distinguish the level at which such regulation occurs. We considered two models: regulation of *dbl-1* transcription and regulation of DBL-1 protein distribution or stability. To distinguish between these possibilities, we used a transgenic strain (BW1935) that expresses GFP driven by the *dbl-1* promoter (*dbl-1p::gfp*) ([@B35]). We RNAi depleted each of these four DBL-1--regulated collagen genes in this strain and determined fluorescence intensity of the nuclear-localized GFP in ventral cord motor neurons in the middle 50% of the worm body axis. Remarkably, we found that loss of these cuticle components is associated with a significant reduction of the expression of the *dbl-1p::gfp* transcriptional reporter at both the L4 and the adult stages for all conditions tested (20--35% at L4 and 40--60% in adults; [Figure 4](#F4){ref-type="fig"}). The large variability in Smad reporter activity and GFP::DBL-1 levels following *col-41(RNAi)* was not seen for the *dbl-1* transcriptional reporter. These results suggest that cuticle collagen genes are capable of regulating DBL-1 at the level of transcription, an unexpected finding because of the physical separation of DBL-1--expressing neurons from the cuticle.

![Loss of cuticle collagen gene function reduces expression of a DBL-1 transcriptional reporter. (A) L4 animals. (B) Young adults. A strain carrying *ctIs43,* a transgene expressing GFP driven by the *dbl-1* promoter, was treated with collagen RNAi as indicated. Fluorescence intensity was measured in L4 (A) or 1-d-old adults (B). AU: arbitrary units. Each data point depicts the intensity of an individual nucleus. Bars show mean and SD of the data. Statistical significance compared with control was determined by Brown--Forsythe and Welch ANOVA tests. \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.](mbc-31-825-g004){#F4}

To exclude the possibility that reduction of *dbl-1p::gfp* expression is due to a general effect on transgene expression under collagen RNAi conditions rather than a specific effect on the *dbl-1* promoter, we analyzed the expression of an independent transgene under the same conditions. We analyzed the effects of collagen gene RNAi on an ectopic, hypodermally expressed GFP::DBL-1 construct (strain TLG633). While exposure to GFP-targeted RNAi significantly reduced GFP::DBL-1 fluorescence, exposure to *col-41, rol-6, col-141,* and *col-142* RNAi caused no significant difference (Supplemental Figure S1). We therefore conclude that inhibition of collagen genes by RNAi does not cause a general reduction of transgene expression, nor does it act directly on GFP::DBL-1, but rather likely acts at the level of *dbl-1* transcription.

Finally, to validate these RNAi results in altered collagen genetic backgrounds, we crossed the *dbl-1* transcriptional reporter into three collagen mutant strains: *rol-6(lf), col-141 col-142(oe),* and a *col-141(lf)* deletion allele generated by CRISPR/Cas9 genome editing ([@B23]). We quantified the GFP intensity from *dbl-1p::gfp* in young adults as a measure of *dbl-1* transcription levels. Surprisingly, in *rol-6(lf)* mutants, GFP expression became undetectable ([Figure 5B](#F5){ref-type="fig"}). Thus, loss of *rol-6* has a major effect on *dbl-1* expression. Similarly, *col-141(lf)* mutants have slightly reduced *dbl-1* expression ([Figure 5, C and E](#F5){ref-type="fig"}). In contrast, *col-141 col-142(oe)* animals have normal levels of *dbl-1* reporter expression ([Figure 5, D and E](#F5){ref-type="fig"}). These results from the *rol-6(lf)* and *col-141(lf)* mutant strains corroborate the findings from the respective RNAi experiments. We conclude that cuticle collagens participate in feedback regulation of DBL-1.

![DBL-1 transcriptional reporter expression in collagen mutant and overexpression strains. The transgene *ctIs43,* expressing GFP driven by the *dbl-1* promoter, is visualized in A, wild-type; B, *rol-6(lf)*; C, *col-141(lf);* and D, *col-141 col-142(oe)* 1-d-old adult hermaphrodites. (A--D) Representative GFP fluorescence images. (A'--D') The same animals visualized with Nomarski DIC optics. Ventral is downward. (E) Fluorescence intensity was measured in 1-d-old adults. Fluorescence was completely undetectable in *rol-6(lf)* animals and could not be quantitated. AU: arbitrary units. Each data point depicts the intensity of an individual nucleus. Bars show mean and SD of the data. Statistical significance compared with control was determined by Brown--Forsythe and Welch ANOVA tests. \*\*\**p* \< 0.001.](mbc-31-825-g005){#F5}

DISCUSSION
==========

In this work, we investigated the reciprocal interactions between the DBL-1/BMP pathway and the specific cuticle collagens, COL-41, ROL-6, COL-141, and COL-142. In previous work, we showed that *col-41, rol-6, col-141*, and *col-142* are transcriptional targets of DBL-1 signaling ([@B23]). They are positive (*col-41*), negative (*col-141*), or dose-sensitive (*rol-6*) regulators of body size ([@B23]). Moreover, DBL-1 signaling mutants have altered cuticle morphology and function ([@B31]). Here we extended those studies to provide evidence that these cuticle collagen genes act downstream of DBL-1 in body size regulation. We used three different measures of DBL-1 pathway signaling to demonstrate that these cuticle collagens, in turn, feed back on DBL-1 signaling. Interestingly, this postulated feedback regulation is consistent with a previous study that shows the ADAMTS-secreted metalloprotease ADT-2 modulates both cuticle collagen organization and DBL-1 signaling activity ([@B11]).

These four DBL-1--regulated collagen genes can be divided into two groups based on temporal expression patterns and loss-of-function phenotypes. One group consists of *col-41* and *rol-6,* which have a peak of expression in the second larval (L2) stage, and loss of either gene product causes a mild small body size phenotype ([@B15]; [@B33]; [@B23]). DBL-1 signaling activates expression of these genes at the L2 stage and represses their expression in adults ([@B23]). Loss of *col-41* caused reduction in *dbl-1* expression, GFP::DBL-1 protein fluorescence, and Smad reporter activity ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, and [4](#F4){ref-type="fig"}). Strikingly, *col-41(RNAi)* consistently resulted in a large variation in Smad activity reporter and GFP::DBL-1 levels, and in some experiments this variation may have contributed to a lack of statistical significance. This variance was not seen in the level of the *dbl-1* transcriptional reporter. One possible explanation is that in *col-41(RNAi)* animals, a compensatory mechanism occurs posttranscriptionally that restores DBL-1 protein levels in a subset of neurons. This intriguing observation invites further elucidation.

Loss of *rol-6* had the most profound effects on DBL-1 signaling, causing significant reductions in expression of a Smad activity reporter, GFP::DBL-1 fusion protein, and a *dbl-1* transcriptional reporter. *C. elegans* body size is also highly sensitive to the level of ROL-6*.* Reduction of the *rol-6* transcript by *rol-6(RNAi)* or by a *rol-6(lf)* mutation reduces body size and significantly suppresses the long body size of *dbl-1(oe)* ([@B23]; [Figure 3](#F3){ref-type="fig"}). Furthermore, *rol-6(oe)* is also small, indicating a dose sensitivity for this gene product in body size regulation. These results extend ROL-6′s functions to include impacting DBL-1 signaling.

The second group comprises *col-141* and *col-142,* which have a peak of expression in the adult stage ([@B14]). Loss of *col-141* causes a mild long body size phenotype. DBL-1 Smads directly regulate these genes, repressing expression at the L2 stage and activating their expression in adults ([@B23]). In spite of the opposite functions of *col-41* and *rol-6* in body size determination, *col-141* and *col-142* act similarly to those genes in reducing DBL-1 signaling activity, as seen in three independent activity reporters ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, and [4](#F4){ref-type="fig"}). Like *col-141(RNAi), col-141(lf)* reduced *dbl-1* reporter transcription ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}); however, *col-141 col-142(oe)*, which has a small body size phenotype, does not affect the *dbl-1* transcriptional reporter. These results dissociate the collagens' effects on body length from DBL-1 pathway activity, so the effect of collagen loss on DBL-1 signaling likely depends on other properties of the cuticle in these backgrounds.

It is well established in various contexts that members of the TGF-β family, including BMPs, regulate ECM, with important consequences for biological function, which can be called "forward" regulation of the ECM ([@B40]; [@B16]). Moreover, the ECM can participate in "reverse" or "feedback" regulation of TGF-β or BMP signaling. For example, type IV collagen controls BMP signaling in *Drosophila* by directly binding Dpp ([@B37]; [@B3]; [@B30]). In addition, the ECM protein fibrillin directly binds TGFβs and BMPs ([@B32]). Mutations in FBN1 result in Marfan syndrome, for which some of the pathologies are attributed to increased TGF-β bioavailability ([@B26]). Similarly, the interaction between fibrillin1 and BMP4 regulates BMP4 bioavailability ([@B27]). Each of these interactions occurs via direct physical contact between ligands and the ECM. Our work, in contrast, supports a novel model of contact-independent regulation of BMP ligand expression and activity by the ECM ([Figure 6](#F6){ref-type="fig"}). The cuticle forms the outermost barrier between the animal and its environment. Its components are synthesized by the underlying hypodermis and secreted to the apical (outer) surface. DBL-1 is secreted from neurons apposed to the basal (internal) side of the hypodermis. DBL-1--expressing cells are thus physically separated from the cuticle, making physical interactions between these cells and cuticle collagens unlikely.

![Model for DBL-1/BMP pathway regulation by cuticle collagens. Green arrows represent forward DBL-1 signaling that regulates cuticle collagen expression and body size. DBL-1/BMP is expressed by and secreted from neurons of the ventral cord. It binds to receptors on the hypodermis (purple complex) and activates Smad signaling. Smad activation causes changes in gene expression leading to altered collagen composition of the cuticle. Yellow arrow depicts feedback signaling from the cuticle to a DBL-1/BMP--expressing cell.](mbc-31-825-g006){#F6}

How can a contact-independent mechanism operate? Biomechanical properties of a tissue can influence gene expression. For example, mesenchymal stem cells commit to different differentiated lineages depending on matrix stiffness ([@B8]). In another example, compression of *Drosophila* embryos (which may mimic forces generated during morphogenetic movements) induces ectopic expression of the transcription factor Twist ([@B10]). Alterations of the *C. elegans* cuticle have also been shown to cause changes in signaling pathways in nonhypodermal tissues. For example, loss of some cuticle collagens alters widely expressed SKN-1/Nrf transcription factor activity and stress responses ([@B7]). Interestingly, classical work on the GLP-1/Notch receptor in *C. elegans* identified mutations in seven cuticle collagen genes that suppress the pharyngeal and germline phenotypes of partial-loss-of-function *glp-1* alleles ([@B24]). They also found the severity of the body size defect associated with loss of collagen function did not correlate with *glp-1* suppression. In this work, we show a similar effect on BMP signaling by loss of a different set of cuticle collagens. The reduction of DBL-1/BMP expression does not correlate with the alteration in body size in these collagen knockdowns. Specifically, RNAi inhibition of *col-41* or *rol-6* results in small animals, while RNAi against *col-141* results in long animals, but each of these treatments reduces DBL-1 reporter activity. Therefore, we conclude that it is not the animal's size but some other feature of the altered cuticle that is responsible for the feedback regulation.

Our model summarizes these observations ([Figure 6](#F6){ref-type="fig"}). The neurons expressing DBL-1 may experience biomechanical forces, such as tension or compression, which modulate gene expression, including *dbl-1* expression. Alterations in the collagen composition of the cuticle affect these forces, leading to changes in gene expression. This phenomenon may be a more widespread mechanism of contact-independent regulation of gene expression and cell signaling, for which the *C. elegans* cuticle may be a useful model. Future studies will identify the biomechanical or other properties of the *C. elegans* cuticle responsible for this proposed feedback. In summary, the DBL-1/BMP pathway provides a unique in vivo model to study bidirectional interactions between cell signaling and the ECM in the context of the intact organism. We propose that reciprocal interactions permit robust yet environmentally responsive control of body size.

MATERIALS AND METHODS
=====================

Strains
-------

*C. elegans* strains were grown at 20°C using standard methods ([@B2]). All experiments were performed at 20°C. In addition to strains generated for this work, the following strains were used: LW2436 *jjIs2436\[pCXT51(RAD-SMAD) + LiuFD61(mec-7p::mRFP)\]* ([@B36])*,* TLG281 *rrf-3(pk1426)*; *texIs100\[dbl-1p::GFP::dbl-1* + *ttx-3p::mRFP\]*; *dbl-1(nk3)* ([@B1])*,* TLG633 *texIs121\[rol-6p::GFP::dbl-1* + *ttx-3p::GFP\],* BW1935 *unc-119(ed3); ctIs43\[dbl-1p::GFP + unc-119(+)\]; him-5(e1490)* ([@B35])*,* MT2709 *rol-6(e187n1270)* (a.k.a *rol-6(lf)*) ([@B18])*,* CS643 *qcEx133\[rol-6(+) + myo-2p::GFP\]* (a.k.a. *rol-6(oe*)*,* CS678 *col-141(qc25\[2xNLS::GFP\])* (a.k.a. *col-141(lf)*)*,* and CS637 *qcEx131\[col-141(+) col-142(+) + myo-2p::GFP\]* (a.k.a. *col-141 col-142(oe)*) ([@B23])*.*

RNAi
----

RNAi by feeding was performed as described ([@B15]; [@B1]; [@B20]). RNAi clones that target the unique (non-Gly-X-Y repeat) regions of collagen genes were generated by cloning PCR fragments encoding these regions into the L4440 vector and transforming bacterial strain HT115 (primer sequences are available on request) ([@B23]).

RAD-SMAD reporter, *dbl-1* transcriptional reporter, and ectopic GFP::DBL-1 imaging
-----------------------------------------------------------------------------------

Fluorescence images were taken with a Zeiss AxioCam MRm camera on a Zeiss Apotome microscope using a 40× objective. For fluorescence quantification, images were taken at 40×. For RAD-SMAD and *dbl-1p::gfp* reporters, fluorescence intensity was determined by manually selecting each individual nucleus and quantifying intensity using ImageJ software. For the RAD-SMAD reporter, we analyzed hypodermal nuclei. For the *dbl-1* transcriptional reporter, we analyzed ventral cord motor neuron nuclei. For the hypodermal GFP::DBL-1 transgene, we selected one or two equivalent regions of interest displaying GFP fluorescence in each animal and quantified fluorescence intensity. In each case, we avoided the head and tail regions. Empty vector (L4440) RNAi was used as a control. Each experiment was performed in two or three trials, and representative trials are shown. In addition to the parent reporter strains, crosses were performed to generate CS657 *ctIs43; rol-6(e187n1270),* CS675 *ctIs43; col-141(qc25)*, and CS677 *ctIs43; qcEx131.*

Body size measurements and GFP::DBL-1 imaging
---------------------------------------------

Populations of TLG281 *rrf-3(pk1426)*; *dbl-1(nk3)*; *texIs100* animals were staged by a standard bleaching technique and grown overnight at 20°C in M9 to hatch and arrest at the L1 stage ([@B34]). Starved hatchlings were plated on bacteria expressing double-stranded RNAi against each gene of interest and grown at 20°C for 5 d, until all animals were young adults. RNAi against the unrelated pseudogene C06C3.5 was used as a control. In addition to the RNAi treatments, the *rol-6(e187n1270)* allele was crossed with *texIs100* to generate CS636 *rol-6(e187n1270); texIs100.*

Adult animals were immobilized with 0.2 mM levamisole in M9 buffer on a 10% agarose pad before imaging ([@B9]). Confocal images were acquired using either a Nikon A1R confocal system or a Nikon Eclipse Ti-E confocal system. We used a 60×/1.40 NA oil CFI Plan Apo VC objective and NIS-Elements Advanced Research software (Nikon Instruments, Melville, NY) to measure and quantify the intensity of the GFP::DBL-1 protein under different conditions. The intensity of the GFP-tagged protein for a selected area was calculated by calculating the mean intensity associated with this area minus the mean intensity of the background. Body length was measured using 10× magnification and NIS AR software.
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======================
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